SPARC Fusion Protein Induces Cellular Adhesive Signaling

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Cheng, Lamei ^a,c   Sage, E Helene ^a,b   Yan, Qi ^a,b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FIBRONECTIN; FOCAL ADHESION KINASE; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEONECTIN; OSTEONECTIN ANTIBODY; PAXILLIN; PLASTIC; PROTEIN ANTIBODY; RAC PROTEIN; UNCLASSIFIED DRUG;

ADSORPTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; BINDING AFFINITY; CELL ADHESION; CELL SPREADING; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENZYME ACTIVATION; EPITHELIUM CELL; FILOPODIUM; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LAMELLIPODIUM; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; REDUCTION; SIGNAL TRANSDUCTION;

ANIMALS; BACULOVIRIDAE; CALCIUM; CATTLE; CELL ADHESION; CELL LINE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FIBROBLASTS; FOCAL ADHESION KINASE 1; FOCAL ADHESIONS; GLYCOPROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PAXILLIN; PSEUDOPODIA; RAC1 GTP-BINDING PROTEIN; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84872669783     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053202     Document Type: Article

References (35)

1. Bradshaw AD, Sage EH, (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107: 1049-1054.
2. Haber CL, Gottifredi V, Llera AS, Salvatierra E, Prada F, et al. (2008) SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated. International Journal of Cancer 122: 1465-1475.
3. Chlenski A, Cohn SL, (2010) Modulation of matrix remodeling by SPARC in neoplastic progression. Semin Cell Dev Biol 21: 55-65.
4. Tai IT, Tang MJ, (2008) SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Updat 11: 231-246.
5. Nagaraju GP, Sharma D, (2011) Anti-cancer role of SPARC, an inhibitor of adipogenesis. Cancer Treat Rev 37: 559-66.
6. McClung HM, Golembieski WA, Schultz CR, Jankowski M, Schultz LR, et al. (2012) Deletion of the SPARC acidic domain or EGF-like module reduces SPARC-induced migration and signaling through p38 MAPK/HSP27 in glioma. Carcinogenesis 33: 275-284.
7. Yan Q, Clark JI, Wight TN, Sage EH, (2002) Alterations in the lens capsule contribute to cataractogenesis in SPARC-null mice. J Cell Sci 115: 2747-2756.
8. Sage H, Vernon RB, Funk SE, Everitt EA, Angello J, (1989) SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix. J Cell Biol 109: 341-356.
9. Bassuk JA, Braun LP, Motamed K, Baneyx F, Sage EH, (1996) Renaturation of SPARC expressed in Escherichia coli requires isomerization of disulfide bonds for recovery of biological activity. Int J Biochem Cell Biol 28: 1031-1043.
10. Bradshaw AD, Bassuk JA, Francki A, Sage EH, (2000) Expression and purification of recombinant human SPARC produced by baculovirus. Mol Cell Biol Res Commun 3: 345-351.
11. Nischt R, Pottgiesser J, Krieg T, Mayer U, Aumailley M, et al. (1991) Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40. Eur J Biochem 200: 529-536.
12. Rempel SA, Golembieski WA, Fisher JL, Maile M, Nakeff A, (2001) SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. J Neurooncol 53: 149-160.
13. Roberts DD, Sherwood JA, Ginsburg V, (1987) Platelet thrombospondin mediates attachment and spreading of human melanoma cells. J Cell Biol 104: 131-139.
14. Tuszynski GP, Rothman V, Murphy A, Siegler K, Smith L, et al. (1987) Thrombospondin promotes cell-substratum adhesion. Science 236: 1570-1573.
15. Varani J, Dixit VM, Fligiel SE, McKeever PE, Carey TE, (1986) Thrombospondin-induced attachment and spreading of human squamous carcinoma cells. Exp Cell Res 167: 376-390.
16. Yan Q, Perdue N, Blake D, Sage EH, (2005) Absence of SPARC in murine lens epithelium leads to increased deposition of laminin-1 in lens capsule. Invest Ophthalmol Vis Sci 46: 4652-4660.
17. Yan Q, Perdue N, Sage EH, (2005) Differential responses of human lens epithelial cells to intraocular lenses in vitro: hydrophobic acrylic versus PMMA or silicone discs. Graefes Arch Clin Exp Ophthalmol 243: 1253-1262.
18. Funk SE, Sage EH, (1993) Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J Cell Physiol 154: 53-63.
19. Burridge K, Chrzanowska-Wodnicka M, (1996) Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 12: 463-518.
20. Engel J, Taylor W, Paulsson M, Sage H, Hogan B, (1987) Calcium binding domains and calcium-induced conformational transition of SPARC/BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues. Biochemistry 26: 6958-6965.
21. Schaller MD, (1996) The focal adhesion kinase. J Endocrinol 150: 1-7.
22. Hanks SK, Ryzhova L, Shin NY, Brabek J, (2003) Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci 8: d982-996.
23. Schaller MD, Parsons JT, (1995) pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol Cell Biol 15: 2635-2645.
24. Giancotti FG, Tarone G, (2003) Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol 19: 173-206.
25. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A, (1992) The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70: 401-410.
26. Ridley AJ, Hall A, (1992) The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389-399.
27. Molloy SS, Thomas L, VanSlyke JK, Stenberg PE, Thomas G, (1994) Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface. EMBO J 13: 18-33.
28. Kupprion C, Motamed K, Sage EH, (1998) SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 273: 29635-29640.
29. Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH, (1992) The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and-BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A 89: 1281-1285.
30. Harlan JM, Harker LA, Reidy MA, Gajdusek CM, Schwarta SM, et al. (1983) Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest 48: 269-274.
31. Huynh MH, Zhu SJ, Kollara A, Brown T, Winklbauer R, et al. (2011) Knockdown of SPARC leads to decreased cell-cell adhesion and lens cataracts during post-gastrula development in Xenopus laevis. Dev Genes Evol 220: 315-327.
32. Sriramarao P, Mendler M, Bourdon MA, (1993) Endothelial cell attachment and spreading on human tenascin is mediated by alpha 2 beta 1 and alpha v beta 3 integrins. J Cell Sci 105 (Pt 4):: 1001-1012.
33. Girard JP, Springer TA, (1996) Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules. J of Biol Chem 271: 4511-4517.
34. Kzhyshkowska J, Workman G, Cardo-Vila M, Arap W, Pasqualini R, et al. (2006) Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J Immunol 176: 5825-5832.
35. Liu P, Lu J, Cardoso WV, Vazir C, (2008) SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase. Mol Biol Cell 19: 248-261.